Kazuhiro Mizukami

Plasma soluble fibrin monomer complex as a marker of coronary thrombotic events in patients with acute myocardial infarction.

T. Nakabayashi, M. Ieko, S. Naito, 2009, The Tohoku journal of experimental medicine.

Soluble fibrin monomer degradation products as a potentially useful marker for hypercoagulable states with accelerated fibrinolysis.

T. Koike, T. Tarumi, T. Nakabayashi, 2007, Clinica chimica acta; international journal of clinical chemistry.

Increase in plasma thrombin-activatable fibrinolysis inhibitor may not contribute to thrombotic tendency in antiphospholipid syndrome because of inhibitory potential of antiphospholipid antibodies toward TAFI activation

T. Koike, T. Atsumi, M. Mukai, 2010, International journal of hematology.

One novel and one recurrent mutation in the PROS1 gene cause type I protein S deficiency in patients with pulmonary embolism associated with deep vein thrombosis

T. Koike, T. Tarumi, I. Mizoguchi, 2006, American journal of hematology.

Protein C Sapporo (protein C Glu 25 → Lys): A heterozygous missense mutation in the Gla domain provides new insight into the interaction between protein C and endothelial protein C receptor

H. Kaneko, H. Mizuno, T. Koike, 2005, Thrombosis and Haemostasis.

Molecular Dynamics Calculations of Wild Type vs. Mutant Protein C: Relationship Between Binding Affinity to Endothelial Cell Protein C Receptor and Hereditary Disease

H. Kaneko, H. Mizuno, Tadashi Murase, 2006, Journal of biomolecular structure & dynamics.